Aperio Group, LLC - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Aperio Group, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$179,000
+79.0%
23,550
+18.2%
0.00%–
Q3 2020$100,000
-30.1%
19,928
-16.8%
0.00%
-100.0%
Q2 2020$143,000
+180.4%
23,944
+109.7%
0.00%–
Q1 2020$51,000–11,417–0.00%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders